Articles by Disease (Colorectal Cancers)

Clinical Trials Targeting Advanced Cancers by Active Immunization of T-cell Defined Tumor Antigens

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1133-1138
Author(s): Hideyuki Ikeda

Therapeutic Angiogenesis by Gene Transfer in Critical Limb and Myocardial Ischemia

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1041-1047
Author(s): Peter Schratzberger, Rudolf Kirchmair, Peter R. Vale and Douglas W. Losordo

Signal Transduction Inhibitors in the Treatment of Breast Cancer

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 201-216
Author(s): Rita Nahta, Gabriel N. Hortobagyi and Francisco J. Esteva

The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 217-223
Author(s): WenJing Liu, Anca Bulgaru, Missak Haigentz, C. A. Stein, Roman Perez-Soler and Sridhar Mani

Pharmacogenetics of Irinotecan

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 225-237
Author(s): G. Toffoli, E. Cecchin, G. Corona and M. Boiocchi

Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 239-251
Author(s): S. Theocharis, A. Margeli and G. Kouraklis

Pharmacological Characteristics of Parenteral IGF-I Administration

Journal: Current Pharmaceutical Biotechnology
Volume: 4
Page: 123-140
Author(s): J. Torrado and C. Carrascosa

TGF-ß / Smad Signaling in Prostate Cancer

Journal: Current Drug Targets
Volume: 4
Page: 197-207
Author(s): Diana Bello-DeOcampo and Donald J. Tindall

From TGF-β to Cancer Therapy

Journal: Current Drug Targets
Volume: 4
Page: 243-250
Author(s): Xuemei Huang and Chung Lee

Survivin: Role in Normal Cells and in Pathological Conditions

Journal: Current Cancer Drug Targets
Volume: 3
Page: 131-152
Author(s): L. O'Driscoll, R. Linehan and M. Clynes